CCM Duopharma, Malaysia to Establish the First Non Live Cell Vaccines Fill and Finish Facility in South East Asia
15 May 2009
 

CCM Duopharma Biotech Berhad (CCMD), a public listed pharmaceutical company on the Kuala Lumpur Stock Exchange (Bursa Malaysia) is set to enhance its position as an innovative player in the pharmaceutical industry when the region’s first non live cell vaccines fill and finish facility becomes operational by the third quarter of 2009.

CCM Duopharma Biotech Berhad Chief Executive Officer, Leonard Ariff bin Abdul Shatar said the 1,000 sq ft fill and finish facility has the ability to compound, fill, freeze dry, cap, inspect, label and pack non live cell vaccines to meet the increasing needs of customers who wish to commercialize and launch their products into the market.

The facility is capable of filling between 1,500 and 2,000 vials per hour. The fill and finish dosage is administered in sterile liquid form with the fill volume ranging from 2ml to 20ml.

“As Malaysia’s competency in biotechnology is still in its infancy, it is logical for us to import vaccines in bulk and package them here. Although it is a niche area, we are confident that with our experience in small volume injectables, we can offer our customers comprehensive competency in manufacturing and filling capabilities on a contract basis,” said Leonard.

“We are confident of tapping into the potential of the human vaccines market and add value to our customers in the long run and cater to their pharmaceutical needs,” Leonard added.

Malaysia’s pharmaceutical industry is one of the fastest growing in Asia Pacific and it has also become increasingly reputable following its ability to develop high quality products of international standard through the adoption of Good Manufacturing Practice (GMP) standards of the European Pharmaceutical Inspection Cooperation Scheme (PIC/s).

Recognizing the growth potential, the Malaysian Government has identified the local pharmaceutical industry as one of the 12 target growth industries in the manufacturing sector for further development and promotion in its Third Industrial Master Plan (IMP3) from 2006 to 2020, which is expected to drive the industry to a higher level of global competitiveness.

In this regard, Malaysian pharmaceutical manufacturers are encouraged to undertake higher value-added activities and venture into new growth areas, which include the human vaccines market.

CCM Duopharma Biotech Berhad (CCMD) is a subsidiary of CCM Berhad, which is listed on the main board of Bursa Malaysia and is a key player in the fertilisers, chemicals and pharmaceuticals industries. CCMD was established as a pharmaceutical trading company in 1979 and was involved in the import and marketing of pharmaceutical products. It has since become a leading manufacturer of pharmaceutical products in Malaysia and exports to countries such as Vietnam, Philippines, Sudan, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore and Hong Kong. Its range of products includes tablets, capsules, syrup, creams, haemodialysis solution, sterile irrigation solution, sterile powder injectables, small volume injectables, dental cartridges and eye drop preparations.

Further information about CCMD can be obtained from our website at www.duopharma.com.my



CCM Duopharma Biotech Berhad - Fill and Finish Facility Technical Info-sheet


  Description Technical Information
PRODUCT Product Type Inert Vaccine / Biotech (Recombinant DNA/Protein) Sterile liquid
Dosage Form Vials (Type 1 Amber or clear)
Packing Fill Volume 2 ml to 20 ml
Vial Size 22 mm diameter
FACILITY Vial Washing Room Grade D
Compounding Room Grade A/B (A Environment in B background)
Filling Room Grade A/B (A Environment in B background)
Freeze Dryer Grade A/B (A Environment in B background)
Capping Room Grade A/C (A Environment in C background)
EQUIPMENT Washing Machine Bausch and Strobel, Germany. Model FAW 1005,
Capacity: 1500-2500 units/hour.
Compounding Vessel 50 Liters to 100 Liters.
Filling Machine Rota, Germany, Model: FLR 50/G
Capacity: 1500-2000 vials / hour.
Capping Machine Rota, Germany, Model: FLR 50/B
Capacity: 1500-2000 vials / hour.
Freeze Dryer Telstar, Spain/China, Model: LYOMEGA 40 ST 2.7/65 TFE
Capacity: 10,000 vials / cycle Vial 16 mm diameter.
Inspection Mpack, Germany, Model: Mpack1136,
Capacity: 2200 vials / hour.
Labeling Komark, Malaysia, Model: WS100C2LP,
Capacity: 3000 vials / hour.
GMP GMP compliance European PIC/s (Pharmaceuticals Inspection Cooperation scheme)
WHO guide Malaysian NPCB (National Pharmaceutical Control Bureau)
PROCESS Option 1 Compounding, Filling, Freeze Drying, Capping, Inspection, Labeling, Packing.
Option 2 Inspection, Labeling, Packing

For further information, please contact Mr. Ibrahim Zainudin (General Manager, Operations) at tel. +603 3323 2759 ext 1124 or e-mail at ibrahim-zainudin@duopharma.com.my

ooOoo

Issued by Chemical Company of Malaysia Berhad
For further information, please contact Mr. Ibrahim Zainudin (General Manager, Operations) at tel. +603 3323 2759 ext 1124 or e-mail at ibrahim-zainudin@duopharma.com.my

 
 
About CCM Business Activities Investor Relations Media Centre Career Centre Contact Us Solutions by WEBSEImportant legal information - please read the Privacy Policy & Disclaimer before proceeding.
Copyright © 2010 Chemical Company of Malaysia Bhd. All Rights Reserved.